Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 124040
Published online Nov 15, 2026. doi: 10.4251/wjgo.124040
Published online Nov 15, 2026. doi: 10.4251/wjgo.124040
Figure 2 Subgroup analysis for overall survival based on neutrophil-to-lymphocyte ratio.
iCCA: Intrahepatic cholangiocarcinoma; eCCA: Extrahepatic cholangiocarcinoma; CCA: Cholangiocarcinoma; HR: Hazard ratio; CI: Confidence interval.
- Citation: Cai WM, Jiang W, He BF, Yu JJ, Zeng XH, Peng L, Liu S. Elevated pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in cholangiocarcinoma: A large-scale meta-analysis of 48 cohorts. World J Gastrointest Oncol 2026; 18(11): 124040
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/124040.htm
- DOI: https://dx.doi.org/10.4251/wjgo.124040